Clinical Trial Update: Gene Therapy in Treating Patients With Recurrent Head and Neck Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating a gene therapy for patients with recurrent head and neck cancer. The current status of the trial is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer

Snippet

Sponsor: Aventis Pharmaceuticals | Conditions: Head and Neck Cancer | Phase 2 | Status: UNKNOWN